NFE2L2 and Alzheimer disease: The phosphorylation and subsequent deactivation of nuclear factor erythroid 2-like factor 2 (Nrf2) in AD patients prevents the increased expression of the 20S proteasome (Ramsey et al., 2007; Pickering et al., 2012), which dwindles the already diminishing pool of competent proteasomes.